PAR 0.00% 30.0¢ paradigm biopharmaceuticals limited..

Ann: Trading Halt, page-52

  1. 289 Posts.
    lightbulb Created with Sketch. 79
    The most useful recent announcement that favours our path to DMOAD is the canine 3 year equivalent study. Incredible results and look through to DMOAD.

    Then it becomes a question of our 12 month readout (imminent) followed by my assertion that it becomes a question of who we want to partner with vs hoping someone will partner with us.

    Let’s see!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $104.9M
Open High Low Value Volume
30.0¢ 31.0¢ 29.5¢ $89.62K 294.9K

Buyers (Bids)

No. Vol. Price($)
3 20607 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 16773 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.